Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
09939 KINTOR PHARMA-B
RT Nominal up1.130 +0.030 (+2.727%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others184,366-23.261%240,250223,686174,61298,369
Land & other Lease Assets37,477-11.249%42,22738,61412,06814,412
Intangible Assets148,940-36.796%235,648235,621209,760179,299
Interests in Asso. & JCEs17,9970.290%17,945000
Other Non-current Assets7,895-29.490%11,19744,17334,41940,683

396,675-27.517%547,267542,094430,859332,763
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories0--603,503351,36200
Trade Receivables0--0000
Cash & Bank Balances445,499-48.502%865,081930,1491,065,588195,532
Other Current Assets27,058-31.124%39,285244,384355,02825,081
Assets Held for Sale0--0000

472,557-68.661%1,507,8691,525,8951,420,616220,613
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables81,601-54.767%180,401172,95628,811947
S-T Debt & Leases118,23014.414%103,3359,46986,31361,786
Other Current Liabilities24,899-27.600%34,39137,31554,20979,850
Liab asso w/ Assets Held for Sale0--0000

224,730-29.358%318,127219,740169,333142,583
Net Current Assets247,827-79.170%1,189,7421,306,1551,251,28378,030
Total Assets Less Current Liabilities644,502-62.896%1,737,0091,848,2491,682,142410,793
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases135,690-25.873%183,051150,264135,3902,311
Other Non-current Liabilities50,700-13.731%58,77042,82738,81838,818

186,390-22.922%241,821193,091174,20841,129
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital3150.000%31527326117
  Reserves457,797-69.376%1,494,8731,654,8851,507,673369,647
  Others0--0000
Shareholders' Funds458,112-69.361%1,495,1881,655,1581,507,934369,664
Non-controlling Interests0--0000
Others0--0000

458,112-69.361%1,495,1881,655,1581,507,934369,664
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments44,628-5.557%47,25417,64234,01973,009
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 05/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -71,493,000
%Change-66.295%
EPS / (LPS)RMB -0.170
NBV Per Share (¥)RMB 0.875
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.